Shire PLC (LON:SHP)‘s stock had its “buy” rating restated by equities researchers at Liberum Capital in a research note issued to investors on Monday. They currently have a GBX 5,500 ($73.26) price objective on the biopharmaceutical company’s stock. Liberum Capital’s price objective indicates a potential upside of 7.95% from the stock’s current price.

SHP has been the topic of a number of other reports. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a GBX 6,300 ($83.91) price objective on shares of Shire PLC in a research report on Tuesday, August 16th. BNP Paribas reiterated an “outperform” rating and issued a GBX 5,700 ($75.92) price objective on shares of Shire PLC in a research report on Wednesday, June 15th. Deutsche Bank AG reiterated a “buy” rating and issued a GBX 5,600 ($74.59) price objective on shares of Shire PLC in a research report on Monday, June 13th. Morgan Stanley reiterated an “overweight” rating and issued a GBX 5,600 ($74.59) price objective on shares of Shire PLC in a research report on Friday, June 3rd. Finally, Jefferies Group increased their price objective on Shire PLC from GBX 6,050 ($80.58) to GBX 6,600 ($87.91) and gave the company a “buy” rating in a research report on Wednesday, August 3rd. One analyst has rated the stock with a sell rating, one has assigned a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. Shire PLC currently has an average rating of “Buy” and an average target price of GBX 5,841.33 ($77.80).

Shire PLC (LON:SHP) opened at 5111.00 on Monday. Shire PLC has a 52 week low of GBX 2,707.19 and a 52 week high of GBX 5,180.00. The stock’s market cap is GBX 34.90 billion. The firm has a 50-day moving average price of GBX 4,943.59 and a 200-day moving average price of GBX 4,416.34.

The business also recently announced a dividend, which will be paid on Friday, October 7th. Investors of record on Thursday, September 8th will be given a GBX 3.51 ($0.05) dividend. This represents a dividend yield of 0.07%. The ex-dividend date of this dividend is Thursday, September 8th.

In related news, insider Bohuon,Olivier bought 134 shares of the stock in a transaction that occurred on Thursday, June 30th. The shares were acquired at an average price of GBX 4,463 ($59.44) per share, with a total value of £5,980.42 ($7,965.40).

Shire PLC Company Profile

Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.